Ombitasvir (ABT 267), Ritanavir Boost with Dastasbuvir (ABT 333) and Prataspravir (ABT 450) with or without Ribavirin (RBV) in G1 Special Population in Hemodialysis (HD) in Chronic Hepatitixs C (HCV) Patients Drop C Trial
2016; Elsevier BV; Volume: 64; Issue: 2 Linguagem: Inglês
10.1016/s0168-8278(16)01577-4
ISSN1600-0641
AutoresPatrick Basu, Neal Shah, Mark M. Aloysius, L. Kavali, Elona Shehi,
Tópico(s)Hepatitis Viruses Studies and Epidemiology
Referência(s)